Literature DB >> 4029396

Site specificity of iron removal from transferrin by alpha-ketohydroxypyridine chelators.

G J Kontoghiorghes, R W Evans.   

Abstract

The site specificity of the removal of iron from diferric human transferrin, at pH 7.4, by two alpha-ketohydroxypyridine chelators, 1,2-dimethyl-3-hydroxypyrid-4-one (L1) and mimosine, has been investigated using urea-polyacrylamide gel electrophoresis. Chelator L1 removes iron preferentially from the C-terminal site whereas mimosine shows a small preference for iron in the N-terminal site. The removal of iron has also been followed spectrophotometrically and by monitoring the loss of 59Fe from [59Fe]transferrin. Both chelators are able to remove iron completely from diferric transferrin without additional mediators or reducing agents.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4029396     DOI: 10.1016/0014-5793(85)80859-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  G1/S cell cycle blockers and inhibitors of cyclin-dependent kinases suppress camptothecin-induced neuronal apoptosis.

Authors:  D S Park; E J Morris; L A Greene; H M Geller
Journal:  J Neurosci       Date:  1997-02-15       Impact factor: 6.167

2.  Comparative study of iron mobilization from haemosiderin, ferritin and iron(III) precipitates by chelators.

Authors:  G J Kontoghiorghes; S Chambers; A V Hoffbrand
Journal:  Biochem J       Date:  1987-01-01       Impact factor: 3.857

3.  Changes in transferrin saturation after treatment with the oral iron chelator deferiprone in patients with iron overload.

Authors:  F N al-Refaie; C E De Silva; B Wonke; A V Hoffbrand
Journal:  J Clin Pathol       Date:  1995-02       Impact factor: 3.411

4.  Terephthalamide-containing ligands: fast removal of iron from transferrin.

Authors:  Rebecca J Abergel; Kenneth N Raymond
Journal:  J Biol Inorg Chem       Date:  2007-11-08       Impact factor: 3.358

5.  EIF3 p170, a mediator of mimosine effect on protein synthesis and cell cycle progression.

Authors:  Zizheng Dong; Jian-Ting Zhang
Journal:  Mol Biol Cell       Date:  2003-05-29       Impact factor: 4.138

6.  Requirements for activation of CD8+ murine T cells. I. Development of cytolytic activity.

Authors:  D C Cronin; D W Lancki; F W Fitch
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

Review 7.  [The decomposition of reducing sugars and amines in the Maillard reaction].

Authors:  F Ledl
Journal:  Z Ernahrungswiss       Date:  1991-02

Review 8.  Mechanistic Insights of Chelator Complexes with Essential Transition Metals: Antioxidant/Pro-Oxidant Activity and Applications in Medicine.

Authors:  Viktor A Timoshnikov; Olga Yu Selyutina; Nikolay E Polyakov; Victoria Didichenko; George J Kontoghiorghes
Journal:  Int J Mol Sci       Date:  2022-01-23       Impact factor: 5.923

9.  Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A.

Authors:  Mainul Hoque; Hartmut M Hanauske-Abel; Paul Palumbo; Deepti Saxena; Darlene D'Alliessi Gandolfi; Myung Hee Park; Tsafi Pe'ery; Michael B Mathews
Journal:  Retrovirology       Date:  2009-10-13       Impact factor: 4.602

Review 10.  Iron and Chelation in Biochemistry and Medicine: New Approaches to Controlling Iron Metabolism and Treating Related Diseases.

Authors:  George J Kontoghiorghes; Christina N Kontoghiorghe
Journal:  Cells       Date:  2020-06-12       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.